Neurodawn Pharmaceutical Co., Ltd.
8 clinical trials · Sponsor
◉ Watch Neurodawn Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Y-6 Sublingual Tablets for Acute Penetrating Artery Infarction (NCT07721545) | Neurodawn Pharmaceutical Co., Ltd. | 2026-08-31 |
| Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in U.S. Healthy Participants (NCT07618715) | Neurodawn Pharmaceutical Co., Ltd. | 2026-06-30 |
| Y-4 to Treat the Postherpetic Neuralgia (NCT07275762) | Neurodawn Pharmaceutical Co., Ltd. | 2026-02-02 |
| RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction (NCT07166380) | Neurodawn Pharmaceutical Co., Ltd. | 2025-09-20 |
| Y-3 for Injection in Patients With Hepatic Insufficiency and Healthy Subjects (NCT07055412) | Neurodawn Pharmaceutical Co., Ltd. | 2025-07-10 |
| Pharmacokinetic Effect of Y-3 on Repaglinide，Warfarin and Omeprazole in Healthy Participants (NCT07068841) | Neurodawn Pharmaceutical Co., Ltd. | 2025-05-18 |
Track Neurodawn Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.